Blog

Shikha Jain: Women in Medicine continue to be untitled and “voluntold”

Photo taken from www.taketheleadwomen.com

May 3, 2024, 07:25

Shikha Jain: Women in Medicine continue to be untitled and “voluntold”

Shikha Jain

“New Study Highlights Women’s Impact in Medicine Recent research in the Annals of Internal Medicine reveals that patients treated by female doctors have lower mortality and readmission rates than those treated by male doctors, such data is recognized.

Shikha Jain

It’s disheartening that these findings aren’t already central to healthcare discussions. Studies consistently show that female physicians achieve better patient outcomes, yet the need for a more inclusive healthcare environment remains.

Shikha Jain

The Women in Medicine nonprofit and annual WIM Summit are at the forefront of change, advocating for retention and empowerment of Women In Medicine. These initiatives not only support women in medicine but equip them with the skills to excel and lead.

Shikha Jain

Despite all the data, Women In Medicine continue to be untitled, harassed, overlooked for leadership, underfunded, underpaid, and ‘voluntold’ to do work that is uncompensated and unappreciated, but necessary for healthcare systems to thrive.”

Shikha Jain: Women in Medicine continue to be untitled and “voluntold”

Source: Shikha Jain/X

Shikha Jain is an associate professor of medicine in the Division of Hematology and Oncology at the University of Illinois Cancer Center in Chicago. She is the Director of Communication Strategies in Medicine and the Associate Director of Oncology Communication & Digital Innovation. She is a founder and Chair of the Women In Medicine Summit, and founder and President of the Women in Medicine® non-profit. She is the co-founder of the Rush Center for the Advancement of Women in Health Care. Dr. Jain was named a Rising Star in Medicine by Medscape in 2020 and one of Modern Healthcare’s Top 25 Emerging Leaders in 2019, and was also awarded the Rising Star award by the LEAD Oncology Conference in 2019 and nominated in 2020 as a Women Leader in Oncology.